Literature DB >> 7926263

Differential binding and activation of thyroid hormone response elements by TR alpha 1 and RXR alpha-trap heterodimers.

T Miyamoto1, S Suzuki, L J DeGroot.   

Abstract

Thyroid hormone receptor (TR) forms homo- and heterodimers on various thyroid hormone response elements (TREs). We wished to clarify the relationship of homo- and heterodimer binding to TREs and their trans-activation. We investigated binding characteristics in gel mobility shift assays using synthetic direct repeat (DR) TREs having the consensus motifs separated by different oligonucleotide gaps, and we compared binding to trans-activation mediated via the direct repeat TRE. HTR alpha 1 purified from E. coli formed a monomer and homodimer on DR-TRE +0 to +5 but binding did not closely correlate with T3-dependent trans-activation. When RXR alpha expressed in COS 1 cell was added to purified TR alpha 1 in the gel shift assays, TR/RXR heterodimers were formed, and binding of heterodimers correlated highly with the level of trans-activation. These results strongly suggest that TR/TRAP heterodimers mediate the effect of thyroid hormone on DR-TREs. We also found T3-dependent disruption of homodimer formation on DR +0 to +2 and that T3 increased heterodimer formation on these TREs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926263     DOI: 10.1016/0303-7207(94)90104-x

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  A Purkinje cell protein-2 intronic thyroid hormone response element binds developmentally regulated thyroid hormone receptor-nuclear protein complexes.

Authors:  S G Hagen; R J Larson; K A Strait; J H Oppenheimer
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

2.  Small-molecule hormones: molecular mechanisms of action.

Authors:  Monika Puzianowska-Kuznicka; Eliza Pawlik-Pachucka; Magdalena Owczarz; Monika Budzińska; Jacek Polosak
Journal:  Int J Endocrinol       Date:  2013-02-28       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.